Paul Grint

Has extensive clinical experience in the fields of immunology, infectious diseases, and oncology. Previously served as VP and head of clinical research and development at Pfizer Inc. Also held management postions at IDEC Pharmaceuticals Corp., Schering-Plough Corp., and Wellcome Research Laboratories. He is the author or co-author of more than 50 publications.

  • 2005 Second Quarter

Added to: Illumina Inc. - San Diego, CA

Illumina develops tools for the research of genetics. Revenues are $4 billion.